Table Filtering
Other Information
Release Statistics Download
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources October 9, 2024
Displaying entries 61626 - 61650 of 71927 in total
Disease ID Disease Name Alliance of Genome Resources ID ▲ Species Gene ID Gene Symbol FlyGlycoDB Evidence Code Names References
DOID:655 inherited metabolic disorder SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:1852 intrahepatic cholestasis SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:7148 rheumatoid arthritis SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:3883 Lynch syndrome SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:2841 asthma SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:6000 congestive heart failure SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:9351 diabetes mellitus SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:0112182 mismatch repair cancer syndrome SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:8778 Crohn's disease SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:14365 systemic primary carnitine deficiency disease SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:1920 hyperuricemia SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:783 end stage renal disease SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:0050908 myelodysplastic syndrome SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:3021 acute kidney failure SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:13619 extrahepatic cholestasis SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:1074 kidney failure SGD:S000000695 Saccharomyces cerevisiae S288C 850462 GIT1
  • MGI:6194238
DOID:0080569 congenital disorder of glycosylation Ir SGD:S000000728 Saccharomyces cerevisiae S288C 856716 WBP1
  • MGI:6194238
DOID:13268 porphyria SGD:S000000737 Saccharomyces cerevisiae S288C 856705 GLC3
  • MGI:6194238
DOID:2750 glycogen storage disease IV SGD:S000000737 Saccharomyces cerevisiae S288C 856705 GLC3
  • MGI:6194238
  • PMID:8463281
DOID:2957 pulmonary tuberculosis SGD:S000000737 Saccharomyces cerevisiae S288C 856705 GLC3
  • MGI:6194238
DOID:10754 otitis media SGD:S000000742 Saccharomyces cerevisiae S288C 856699 NPP2
  • MGI:6194238
DOID:13207 proliferative diabetic retinopathy SGD:S000000742 Saccharomyces cerevisiae S288C 856699 NPP2
  • MGI:6194238
DOID:9352 type 2 diabetes mellitus SGD:S000000742 Saccharomyces cerevisiae S288C 856699 NPP2
  • MGI:6194238
DOID:3068 glioblastoma SGD:S000000742 Saccharomyces cerevisiae S288C 856699 NPP2
  • MGI:6194238
DOID:2738 pseudoxanthoma elasticum SGD:S000000742 Saccharomyces cerevisiae S288C 856699 NPP2
  • MGI:6194238

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024